ACRS Q2 2020 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M-65.1% YoY

Gross Profit

$657,00032.1% margin

Operating Income

-$11M-556.3% margin

Net Income

-$12M-566.8% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+45.4%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$85M

Total Liabilities

$36M

Stockholders' Equity

$49M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$6M	-65.1%
Gross Profit	$657,000	$3M	-79.2%
Operating Income	-$11M	-$50M	+77.1%
Net Income	-$12M	-$50M	+76.7%

Revenue Segments

Laboratory Research Revenue

$2M91%

Other Revenue

$193,0009%